Extraction method and application of animal intestine tissue cell nucleus

By using specific prepared intestinal tissue dissociation fluid and extraction steps, the problem of single-cell nucleus extraction of intestinal tissues in multiple species has been solved, and efficient and suitable nucleus extraction of intestinal tissues is achieved, suitable for single-cell nucleus sequencing, improving the application of research value.

CN118956731APending Publication Date: 2024-11-15SINGLERON NANJING BIOTECHNOLOGIES LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411220479.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-02
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art lacks single-cell nuclear extraction methods for intestinal tissue suitable for multiple species, especially fresh or frozen intestinal tissue, resulting in limited application of single-cell transcriptome research.

Method used

The intestinal tissue nucleus dissociation solution containing surfactants, ionic compounds, buffers, reducing agents, inhibitors and solvents was successfully extracted through incubation, filtration and centrifugation, which was suitable for intestinal tissue in different parts.

Benefits of technology

In a short time, the single-cell nucleus is efficiently isolated, and the nucleus is good and has high integrity. It is suitable for single-cell nucleus sequencing experiments and has high commercial application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956731A_ABST
    Figure CN118956731A_ABST
Patent Text Reader

Abstract

The invention discloses an extraction method and application of animal intestine tissue cell nucleuses. Mixing the intestinal tissue with the intestinal tissue nucleus dissociation liquid, then carrying out first incubation and second incubation on ice, reversing and uniformly mixing during incubation to obtain an extract, carrying out primary filtration and secondary filtration on the extract, fixing the volume after filtration to obtain an extracting solution, centrifuging the extracting solution, discarding the supernatant, and then carrying out resuspension precipitation to obtain the intestinal tissue nucleus dissociation liquid. And after resuspending, discarding the supernatant to obtain a precipitate which is the animal intestine tissue cell nucleus. The intestinal tissue nucleus dissociation liquid comprises a surfactant, an ionic compound, a buffer solution, a reducing agent, an inhibitor and a solvent. The prepared intestinal tissue nucleus dissociation liquid can successfully separate and extract single cell nucleuses from intestinal tissues in a short time, the obtained cell nucleuses are good in state and relatively high in integrity, the method for extracting the cell nucleuses is suitable for the intestinal tissues of different parts, the obtained cell nucleus suspension can be used for single cell nucleus sequencing experiments, and the method is suitable for large-scale popularization and application. The method has high commercial application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of cell nucleus extraction and relates to a method for extracting animal intestinal tissue cell nuclei and application thereof. Background Art

[0002] There are no two identical leaves in the world. For multicellular organisms, there are differences between cells. Often, a slight error in the genome or transcriptome can lead to a huge difference in function. Single-cell sequencing is not just sequencing a cell, but rather that the technology can sequence the genome or transcriptome of a single cell, which can be understood as sequencing at the single-cell level. scRNA-seq has very high requirements for the quality of cell suspension (cell number, activity, concentration, background interference, etc.), so the preparation of cell suspension is only suitable for fresh tissue or frozen and resuscitated tissue (mainly the former), which limits the scope of application of scRNA-seq, meaning that a large number of precious samples with important scientific research and clinical value stored in ultra-low temperature refrigerators cannot be sequenced by scRNA. A large amount of literature has proven that snRNA-seq can solve the main problems in scRNA-seq.

[0003] The intestine is a highly sophisticated organ that shoulders the functions of digestion and absorption, transport, immune diagnosis and immune regulation, and the intestine coexists harmoniously with a large number of microorganisms. The intestine is usually composed of the large intestine and the small intestine, each of which is divided into different regions. Studies have found that the cell composition of different intestinal regions varies greatly, and the specificity of their structure increases the difficulty of extracting cell nuclei. In addition, as the largest digestive organ, the intestine is also the largest excretory organ. The large amount of impurities attached to the inner wall of the intestine is also a problem for the extraction of single cell nuclei in the intestine. There are relatively many studies on single-cell transcriptomes at this stage. Single-cell transcriptomes are relatively stable in terms of dissociation methods and data indicators. However, for some samples that have been frozen in the early stage, single-cell nuclear dissociation can be well applied to frozen samples. While avoiding sample waste, data different from single-cell dissociation can also be obtained, thereby further understanding the complexity of intestinal cells.

[0004] Given the specificity of intestinal tissue, most of the single-cell transcriptome studies on intestinal tissue reported so far have involved relatively more single-cell extractions from fresh intestinal tissue, but there are almost no definitive methods for extracting single-cell nuclei from fresh or frozen intestinal tissue.

[0005] Therefore, there is an urgent need to develop a single-cell nucleus extraction method that can be applied to intestinal tissues of multiple species. Summary of the invention

[0006] In view of the deficiencies of the prior art and actual needs, the object of the present invention is to provide a method for extracting animal intestinal tissue cell nuclei and its application, which is suitable for the extraction of single cell nuclei from intestinal tissue of multiple species.

[0007] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:

[0008] In a first aspect, the present invention provides a method for extracting animal intestinal tissue cell nuclei, the extraction method comprising:

[0009] The intestinal tissue is mixed with the intestinal tissue nuclear dissociation solution, and then incubated for the first time and the second time on ice, and the mixture is mixed by inversion during the incubation to obtain an extract, and the extract is filtered for the first time and the second time, and the volume is fixed after filtration to obtain an extract solution, and the extract solution is centrifuged, and the supernatant is discarded and the precipitate is resuspended, and the supernatant is discarded after resuspending to obtain the precipitate, which is the intestinal tissue cell nucleus of the animal;

[0010] The intestinal tissue nuclear dissociation solution comprises a surfactant, an ionic compound, a buffer, a reducing agent, an inhibitor and a solvent.

[0011] The intestinal tissue nuclear dissociation solution prepared by the present invention can successfully separate and extract single cell nuclei from intestinal tissue in a relatively short time. The obtained cell nuclei are in good condition and have relatively high integrity. The method for extracting cell nuclei is applicable to intestinal tissues in different parts. The obtained cell nucleus suspension can be used for single cell nucleus sequencing experiments and has high commercial application value.

[0012] Preferably, the mass volume ratio of the intestinal tissue to the intestinal tissue nuclear dissociation solution is 60-140 mg:1 mL, for example, it can be 60 mg:1 mL, 80 mg:1 mL, 100 mg:1 mL, 120 mg:1 mL, 140 mg:1 mL, etc.

[0013] Preferably, the volume of the intestinal tissue is 1-3 mm 3 , for example, it can be 1.5 mm 3 , 2mm 3 , 2.5mm 3 wait.

[0014] Preferably, the first incubation time is 4-6 min, for example, 4.5 min, 5 min, 5.5 min, etc., and the second incubation time is 6-20 min, for example, 10 min, 15 min, 20 min, etc.

[0015] Preferably, the inversion mixing during the incubation includes the inversion mixing during the first incubation and the second incubation at a rate of 2-3 times / minute, for example, 2 times / minute, 3 times / minute, 4 times / minute, or 5 times / minute.

[0016] Preferably, the surfactant includes Tween 20 and IGEPAL CA-630.

[0017] Preferably, the ionic compounds include NaCl and MgCl2.

[0018] Preferably, the buffer comprises Tris-HCl buffer.

[0019] Preferably, the reducing agent comprises dithiothreitol.

[0020] Preferably, the inhibitor comprises a ribonuclease inhibitor.

[0021] Preferably, the solvent comprises a BSA solution.

[0022] Preferably, the mass percentage of the surfactant in the intestinal tissue nuclear dissociation solution is 0.8-1.2%, for example, it can be 0.8%, 0.9%, 1.0%, 1.1%, 1.2%, etc.

[0023] Preferably, the concentration of NaCl in the ionic compounds in the intestinal tissue nuclear dissociation solution is 8-12mM, for example, it can be 8.8mM, 9.6mM, 10.4mM, 11mM, 11.8mM, etc., and the concentration of MgCl2 is 2-4mM, for example, it can be 2.3mM, 2.6mM, 2.9mM, 3.2mM, 3.5mM, etc.

[0024] Preferably, the concentration of dithiothreitol in the intestinal tissue nuclear dissociation solution is 0.8-1.2 mM, for example, it can be 0.85 mM, 0.9 mM, 0.95 mM, 1.0 mM, 1.05 mM, 1.1 mM, 1.15 mM, etc.

[0025] Preferably, the concentration of Tris-HCl buffer in the intestinal tissue nuclear dissociation solution is 8-12 mM, for example, it can be 8.5 mM, 9 mM, 9.5 mM, 10 mM, 10.5 mM, 11 mM, 11.5 mM, etc.

[0026] Preferably, the enzyme activity concentration of the ribonuclease inhibitor in the intestinal tissue nuclear dissociation solution is 0.8-1.2 U / μL, for example, it can be 0.85 U / μL, 0.9 U / μL, 0.95 U / μL, 1 U / μL, 1.05 U / μL, 1.1 U / μL, 1.15 U / μL, etc.

[0027] Preferably, the pH value of the intestinal tissue nuclear dissociation solution is 7.0-8.0.

[0028] Preferably, the solvent in the intestinal tissue nuclear dissociation solution is BSA buffer.

[0029] Preferably, the pore size of the filter for the initial filtration is 65-75 μm (for example, 68 μm, 70 μm, 75 μm, etc.), and the pore size of the filter for the secondary filtration is 35-45 μm (for example, 38 μm, 42 μm, 45 μm, etc.).

[0030] Preferably, the centrifugal speed is 400-600rcf (for example, 440rcf, 480rcf, 520rcf, 560rcf, etc.), the temperature is 3-5°C (for example, 3.5°C, 4°C, 4.5°C, etc.), and the time is 4-6min (for example, 4.5min, 5min, 5.5min, etc.).

[0031] Preferably, the resuspending the precipitate comprises resuspending the precipitate using a cell nucleus resuspending reagent or a washing reagent.

[0032] Preferably, the resuspension reagent comprises ribonuclease inhibitor, fetal bovine serum and PBS.

[0033] Preferably, the final concentration of the ribonuclease inhibitor in the resuspension reagent is 0.1-0.3 U / μL, for example, 0.1 U / μL, 0.15 U / μL, 0.2 U / μL, 0.25 U / μL, 0.3 U / μL, etc.

[0034] Preferably, the mass percentage of fetal bovine serum in the resuspension reagent is 1%-3%, for example, it can be 1%, 1.5%, 2.%, 2.5%, 3%, etc.

[0035] Preferably, the pH of the resuspension reagent is 7.2-7.6, for example, it can be 7.2, 7.3, 7.4, 7.5, 7.6, etc.

[0036] Preferably, the washing reagent comprises: 9-11 mM Tris-HCl, 9-11 mM NaCl, 2-4 mM MgCl2, 0.5-2% BSA, 0.5-2 mM DTT, 0.5-2 U / μL ribonuclease inhibitor and 0.05-0.2% Tween 20.

[0037] As a preferred technical solution, the present invention provides a method for extracting animal intestinal tissue cell nuclei, the extraction method comprising the following steps:

[0038] (1) Mix the intestinal tissue with intestinal tissue nuclear dissociation solution at a ratio of 60-140 mg:1 mL, and cut the intestinal tissue into pieces of 1-3 mm. 3, incubate on ice for 4-6 minutes for the first time, mix by inversion 2-5 times / minute during the incubation period, then add a cell nucleus washing reagent with a pH value of 7.0-8.0, incubate on ice for a second time for 6-20 minutes, mix by inversion 2-5 times / minute during the incubation period, to obtain an extract;

[0039] The intestinal tissue nuclear dissociation solution includes 0.8-1.2% Tween 20, 0.8-1.2% IGEPAL CA-630, 8-12mM NaCl, 2-4mM MgCl2, 0.8-1.2mM DTT, 8-12mM Tris-HCl, 0.8-1.2U / μL ribonuclease inhibitor and BSA solution;

[0040] The washing reagent includes: 9-11 mM Tris-HCl, 9-11 mM NaCl, 2-4 mM MgCl2, 0.5-2% BSA, 0.5-2 mM DTT, 0.5-2 U / μL ribonuclease inhibitor and 0.05-0.2% Tween20;

[0041] (2) filtering the extract twice at 65-75 μm and 35-45 μm, and fixing the obtained filtrate with a washing reagent to obtain an extract;

[0042] (3) centrifuging the extract at 400-600 rcf and 3-5° C. for 4-6 min, resuspending the precipitate obtained after centrifugation using a washing reagent or a resuspension reagent, and repeating the centrifugation and resuspension 1-3 times to obtain the precipitate that is the animal intestinal tissue cell nucleus;

[0043] The resuspension reagent includes: 2% BSA, 1 mM DTT, 0.2 U / μL ribonuclease inhibitor and enzyme-free water.

[0044] In a second aspect, the present invention provides an animal intestinal tissue nucleus suspension, wherein the animal intestinal tissue nuclei in the animal intestinal tissue nucleus suspension are prepared by the extraction method described in the first aspect.

[0045] Preferably, the solvent of the animal intestinal tissue cell nucleus suspension includes BSA solution.

[0046] Preferably, the nuclei per unit mass of the intestinal tissue of the animal is (0.08-1.2)×10 5 / mg.

[0047] Above (0.08-1.2)×10 5 The specific point value in / mg can be 0.08×10 5 / mg, 0.09×10 5 / mg, 0.10×10 5 / mg, 0.5×10 5 / mg, 1×10 5 / mg, 1.2×10 5 / mg, etc.

[0048] The numerical range described in the present invention not only includes the point values ​​listed above, but also includes any point values ​​between the above numerical ranges that are not listed. Due to space limitations and for the sake of simplicity, the present invention no longer exhaustively lists the specific point values ​​included in the range.

[0049] Compared with the prior art, the present invention has the following beneficial effects:

[0050] (1) The intestinal tissue nuclear dissociation solution prepared by the present invention can successfully separate and extract single cell nuclei from frozen or fresh intestinal tissue in a short time. The obtained cell nuclei are in good condition and relatively high integrity, which meets the requirements of later RNA Seq research. In addition, the method for extracting cell nuclei is applicable to intestinal tissues of multiple species.

[0051] (2) The extraction method provided by the present invention is simple and convenient to operate and can be completed in only 0.5-1 h. The provided cell nucleus suspension can be used for single cell nucleus sequencing experiments and has high commercial application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0052] Figure 1 This is a trypan blue staining microscopic examination of the intestinal tissue cell nuclear suspension prepared in Example 1-3;

[0053] Figure 2 This is a trypan blue staining microscopic examination of the intestinal tissue cell nuclear suspension prepared in Example 4-5;

[0054] Figure 3 This is a trypan blue staining microscopic examination of the intestinal tissue cell nuclear suspension prepared in Comparative Example 1-3;

[0055] Figure 4 This is a trypan blue staining microscopic examination image of the intestinal tissue cell nuclear suspension prepared in Comparative Example 4;

[0056] Figure 5 This is a trypan blue staining microscopic examination of the intestinal tissue cell nuclear suspension prepared in Comparative Example 5-8;

[0057] Figure 6 This is a trypan blue staining microscopic examination of the intestinal tissue cell nuclear suspension prepared in Comparative Examples 9-11. DETAILED DESCRIPTION

[0058] To further illustrate the technical means and effects of the present invention, the present invention is further described below in conjunction with the embodiments and drawings. It should be understood that the specific implementation methods described herein are only used to explain the present invention, rather than to limit the present invention.

[0059] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.

[0060] As used herein, the terms "comprises," "including," "having," "containing," or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises the listed elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.

[0061] "Optional" or "any one" means that the subsequently described matter or event can or cannot occur, and that the description includes instances where the event occurs and instances where it does not.

[0062] The indefinite articles "a" and "an" before the elements or components of the present invention have no limitation on the quantity requirements (i.e. the number of occurrences) of the elements or components. Therefore, "a" or "an" should be interpreted as including one or at least one, and the elements or components in the singular form also include the plural form, unless the quantity obviously refers to the singular form only.

[0063] The terms "one embodiment", "some embodiments", "exemplarily", "specific examples" or "some examples" described in the present invention mean that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this document, the schematic representation of the above terms does not necessarily refer to the same embodiment or example.

[0064] In the present invention, unless otherwise specified, percentages and percentage contents are all by mass. Unless otherwise specified, the experimental methods used are all conventional methods, and the materials and reagents used can be purchased from commercial sources.

[0065] Washing reagent: 10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl2, 1% BSA, 1 mM DTT, 1 U / μL RNaseInhibitor, 0.1% Tween 20, prepared before the experiment.

[0066] Resuspension reagent: 2% BSA, 1mM DTT, 0.2U / μL RNase Inhibitor, the solvent is enzyme-free water, and the resuspension reagent is prepared before the experiment.

[0067] Example 1

[0068] This embodiment provides a method for extracting animal intestinal tissue cell nuclei, which is as follows:

[0069] (1) Take 23 mg of mouse rectal tissue and place it in a 1.5 mL low-adsorption centrifuge tube. Add 500 μL of intestinal tissue nuclear dissociation solution (1% Tween 20, 1% IGEPAL CA-630, 10 mM NaCl, 3 mM MgCl2, 1 mM DTT, 10 mM Tris-HCl (pH 7.4), 1 U / μL RNase Inhibitor) and cut the intestinal tissue into 1-3 mm pieces. 3 , incubate on ice for 5 min, invert and mix 3 times / min during this period, then add 500 μL of washing reagent and mix evenly, incubate on ice for 10 min, invert and mix 3 times / min during this period, to obtain the extract;

[0070] (2) filtering the extract into a 15 mL low-absorption centrifuge tube using 70 μm and 30 μm filter screens in sequence, adjusting the volume to 1.5 mL using a washing reagent to obtain an extract, and centrifuging at 500 rcf and 4°C for 5 min;

[0071] (3) Discard the supernatant, resuspend the precipitate in 1 mL of washing reagent, and centrifuge again at 500 rcf and 4°C for 5 min;

[0072] (4) Repeat step (3) and wash once;

[0073] (5) Discard the supernatant and resuspend the precipitate with 200 μL of resuspension reagent. The resulting suspension is the intestinal tissue cell nuclear suspension.

[0074] Example 2

[0075] This embodiment provides a method for extracting animal intestinal tissue cell nuclei, which is as follows:

[0076] (1) Take 21 mg of mouse rectal tissue and place it in a 1.5 mL low-adsorption centrifuge tube. Add 500 μL of intestinal tissue nuclear dissociation solution (0.8% Tween 20, 0.8% IGEPAL CA-630, 8 mM NaCl, 2 mM MgCl2, 0.8 mM DTT, 8 mM Tris-HCl (pH 7.4), 0.8 U / μL RNase Inhibitor) and cut the intestinal tissue into 1-3 mm pieces. 3 , incubate on ice for 5 min, invert and mix 3 times / min during this period, then add 500 μL of washing reagent and mix evenly, incubate on ice for 5 min, invert and mix 3 times / min during this period, to obtain the extract;

[0077] (2) filtering the extract into a 15 mL low-absorption centrifuge tube using 70 μm and 30 μm filter screens in sequence, adjusting the volume to 1.5 mL using a washing reagent to obtain an extract, and centrifuging at 500 rcf and 4°C for 5 min;

[0078] (3) Discard the supernatant, resuspend the precipitate in 1 mL of washing reagent, and centrifuge again at 500 rcf and 4°C for 5 min;

[0079] (4) Repeat step (3) and wash once;

[0080] (5) Discard the supernatant and resuspend the precipitate with 200 μL of resuspension reagent. The resulting suspension is the intestinal tissue cell nuclear suspension.

[0081] Example 3

[0082] This embodiment provides a method for extracting animal intestinal tissue cell nuclei, which is as follows:

[0083] (1) Take 30 mg of mouse rectal tissue and place it in a 1.5 mL low-adsorption centrifuge tube. Add 500 μL of intestinal tissue nuclear dissociation solution (1.2% Tween 20, 1.2% IGEPAL CA-630, 12 mM NaCl, 5 mM MgCl2, 1.2 mM DTT, 12 mM Tris-HCl (pH 7.4), 1.2 U / μL RNase Inhibitor) and cut the intestinal tissue into 1-3 mm pieces. 3 , incubate on ice for 6 min, invert and mix 3 times / min during this period, then add 500 μL of washing reagent and mix evenly, incubate on ice for 20 min, invert and mix 3 times / min during this period, to obtain the extract;

[0084] (2) filtering the extract into a 15 mL low-absorption centrifuge tube using 70 μm and 30 μm filter screens in sequence, adjusting the volume to 1.5 mL using a washing reagent to obtain an extract, and centrifuging at 500 rcf and 4°C for 5 min;

[0085] (3) Discard the supernatant, resuspend the precipitate in 1 mL of washing reagent, and centrifuge again at 500 rcf and 4°C for 5 min;

[0086] (4) Repeat step (3) and wash once;

[0087] (5) Discard the supernatant and resuspend the precipitate with 200 μL of resuspension reagent. The resulting suspension is the intestinal tissue cell nuclear suspension.

[0088] Example 4

[0089] The difference from Example 1 is that the sample is human megacolon tissue.

[0090] Example 5

[0091] The difference from Example 1 is that the sample is the colon tissue of mice.

[0092] Comparative Example 1

[0093] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which is different from Example 1 only in that Tween 20 in the intestinal tissue nuclear dissociation solution is replaced by Triton X-100.

[0094] Comparative Example 2

[0095] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that Tween 20 in the intestinal tissue nucleus dissociation solution is replaced by EDTA.

[0096] Comparative Example 3

[0097] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that Tween 20 in the intestinal tissue nucleus dissociation solution is replaced by SDS.

[0098] Comparative Example 4

[0099] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that the concentration of the surfactant in the intestinal tissue nucleus dissociation solution and the washing reagent is changed to 0.1%.

[0100] Comparative Example 5

[0101] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that Tris-HCl (pH 7.4) is not added to the intestinal tissue nuclear dissociation solution.

[0102] Comparative Example 6

[0103] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that NaCl is not added to the intestinal tissue nucleus dissociation solution.

[0104] Comparative Example 7

[0105] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that MgCl2 is not added to the intestinal tissue nucleus dissociation solution.

[0106] Comparative Example 8

[0107] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which is different from Example 1 only in that BSA is not added to the intestinal tissue nucleus dissociation solution.

[0108] Comparative Example 9

[0109] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that Tween 20 is not added to the washing reagent.

[0110] Comparative Example 10

[0111] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that Tween 20 in the washing reagent is replaced by SDS.

[0112] Comparative Example 11

[0113] This comparative example provides a method for extracting animal intestinal tissue cell nuclei, which differs from Example 1 only in that Tween 20 in the washing reagent is replaced by EDTA.

[0114] Test Example 1

[0115] The intestinal tissue cell nuclear suspension prepared in each example and comparative example was observed for its cell nuclear morphology using a trypan blue staining microscope. For example, the trypan blue staining microscope detection image of the intestinal tissue cell nuclear suspension prepared in Example 1 is as follows: Figure 1 The results of the nuclear yield per unit mass and the percentage of nuclear impurities are shown in Table 1.

[0116] Table 1

[0117]

[0118]

[0119] The trypan blue staining microscopy test of the intestinal tissue cell nuclear suspension prepared in Example 1-3 is shown in FIG. Figure 1 As shown. The nuclear membrane integrity of the intestinal tissue cell nuclear suspensions of Examples 1-3 was good and the impurities were less, and the nuclear suspensions were of high quality. The nuclear concentration per unit mass of the nuclear suspensions of Examples 4 and 5 was lower than that of Example 1, but the nuclear membrane status was good ( Figure 2 ), indicating that the method of the present invention can be applied to intestinal tissues of other species and other parts for nucleus extraction.

[0120] In addition, in Comparative Examples 1-3, the surfactant Tween 20 in the intestinal tissue dissociation solution was replaced with Triton X-100, EDTA and SDS, respectively. It was found that the nuclear membrane of the cell nuclear suspension replaced with Triton X-100 was partially broken, the nucleus of the cell nuclear suspension replaced with EDTA was not completely released, and the cell nuclear suspension replaced with SDS had almost no nucleus, indicating that the surfactant Tween 20 in the intestinal tissue dissociation solution can maintain the integrity of the nuclear membrane ( Figure 3 ). Comparative Example 4: The surfactant concentration in the intestinal tissue dissociation solution was changed to 0.1%, and it was found that the cell nucleus suspension after resuspension was severely clumped ( Figure 4). The trypan blue staining microscopy test image of the intestinal tissue cell nuclear suspension prepared in Comparative Example 5-8 is as follows Figure 5 As shown, the nuclei obtained after removing certain components in the intestinal tissue dissociation solution were poor in morphology, and the edges of the nuclear membranes were diffuse and severely broken, indicating that the various components in the intestinal tissue nuclear dissociation solution of the present invention were synergistic in terms of efficacy. In comparative example 9, after removing Tween 20 from the washing reagent, the nuclear suspension had slight impurities, and the nuclei were not released, and the edges of the partially released nuclei were diffuse; in comparative example 10, during the nuclear dissociation process, gelatinous agglomeration appeared, and the nuclear suspension had no nuclei under microscopic examination; in comparative example 11, the nuclei were not released, and the digestion was incomplete; comparative examples 9-11 all show that the use of Tween 20 as a surfactant in the washing reagent is better, and a nuclear suspension with higher integrity can be obtained ( Figure 6 ).

[0121] In summary, the intestinal tissue nuclear dissociation solution prepared in the present invention can successfully separate and extract single cell nuclei from intestinal tissue in a relatively short time, the obtained cell nuclei are in good condition and relatively high integrity, and the method for extracting cell nuclei is suitable for intestinal tissues in different parts.

[0122] The applicant declares that the present invention illustrates the detailed method of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned detailed method, that is, it does not mean that the present invention must rely on the above-mentioned detailed method to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

Claims

1. A method for extracting animal intestinal tissue cell nuclei, characterized in that: The extraction method comprises: The intestinal tissue is mixed with the intestinal tissue nuclear dissociation solution, and then incubated for the first time and the second time on ice, and the mixture is mixed by inversion during the incubation to obtain an extract, and the extract is filtered for the first time and the second time, and the volume is fixed after filtration to obtain an extract solution, and the extract solution is centrifuged, and the supernatant is discarded and the precipitate is resuspended, and the supernatant is discarded after resuspending to obtain the precipitate, which is the intestinal tissue cell nucleus of the animal; The intestinal tissue nuclear dissociation solution comprises a surfactant, an ionic compound, a buffer, a reducing agent, an inhibitor and a solvent.

2. The extraction method according to claim 1, characterized in that The mass volume ratio of the intestinal tissue to the intestinal tissue nuclear dissociation solution is 60-140 mg:1 mL.

3. The extraction method according to claim 1 or 2, characterized in that The volume of the intestinal tissue is 1-3 mm 3 ; Preferably, the first incubation time is 4-6 min, and the second incubation time is 6-20 min; Preferably, the inversion mixing during the incubation includes the inversion mixing during the first incubation and the inversion mixing during the second incubation, each independently at a rate of 2-5 times / minute.

4. The extraction method according to any one of claims 1 to 3, characterized in that The surfactants include Tween 20 and IGEPAL CA-630; Preferably, the ionic compound comprises NaCl and MgCl2; Preferably, the buffer comprises Tris-HCl buffer; Preferably, the reducing agent comprises dithiothreitol; Preferably, the inhibitor comprises a ribonuclease inhibitor; Preferably, the solvent comprises a BSA solution.

5. The extraction method according to any one of claims 1 to 4, characterized in that The mass percentage of the surfactant in the intestinal tissue nuclear dissociation solution is 0.8-1.2%; Preferably, the concentration of NaCl in the ionic compounds in the intestinal tissue nuclear dissociation solution is 8-12 mM, and the concentration of MgCl2 is 2-4 mM; Preferably, the concentration of dithiothreitol in the intestinal tissue nuclear dissociation solution is 0.8-1.2 mM; Preferably, the concentration of Tris-HCl buffer in the intestinal tissue nuclear dissociation solution is 8-12 mM; Preferably, the enzyme activity concentration of the ribonuclease inhibitor in the intestinal tissue nuclear dissociation solution is 0.8-1.2 U / μL.

6. The extraction method according to any one of claims 1 to 5, characterized in that The pH value of the intestinal tissue nuclear dissociation solution is 7.0-8.0; Preferably, the pore size of the filter for the initial filtration is 65-75 μm, and the pore size of the filter for the secondary filtration is 35-45 μm; Preferably, the centrifugal speed is 400-600 rcf, the temperature is 3-5°C, and the time is 4-6 min.

7. The extraction method according to any one of claims 1 to 6, characterized in that The resuspending precipitate comprises resuspending the precipitate using a cell nucleus resuspending reagent or a washing reagent; Preferably, the resuspension reagent comprises ribonuclease inhibitor, fetal bovine serum and PBS; Preferably, the final concentration of the ribonuclease inhibitor in the resuspension reagent is 0.1-0.3U / μL; Preferably, the mass percentage of fetal bovine serum in the resuspension reagent is 1%-3%; Preferably, the pH of the resuspension reagent is 7.2-7.

6.

8. The extraction method according to claim 7, characterized in that The washing reagent includes: 9-11 mM Tris-HCl, 9-11 mM NaCl, 2-4 mM MgCl2, 0.5-2% BSA, 0.5-2 mM DTT, 0.5-2 U / μL ribonuclease inhibitor and 0.05-0.2% Tween 20.

9. The extraction method according to any one of claims 1 to 8, characterized in that The extraction method comprises the following steps: (1) Mix the intestinal tissue with intestinal tissue nuclear dissociation solution at a ratio of 60-140 mg:1 mL, and cut the intestinal tissue into pieces of 1-3 mm. 3 , incubate on ice for 4-6 minutes for the first time, mix by inversion 2-5 times / minute during the incubation period, then add a cell nucleus washing reagent with a pH value of 7.0-8.0, incubate on ice for a second time for 6-20 minutes, mix by inversion 2-5 times / minute during the incubation period, to obtain an extract; The intestinal tissue nuclear dissociation solution includes 0.8-1.2% Tween 20, 0.8-1.2% IGEPAL CA-630, 8-12mM NaCl, 2-4mM MgCl2, 0.8-1.2mM DTT, 8-12mM Tris-HCl, 0.8-1.2U / μL ribonuclease inhibitor and BSA solution; The washing reagent includes: 9-11 mM Tris-HCl, 9-11 mM NaCl, 2-4 mM MgCl2, 0.5-2% BSA, 0.5-2 mM DTT, 0.5-2 U / μL ribonuclease inhibitor and 0.05-0.2% Tween20; (2) filtering the extract twice at 65-75 μm and 35-45 μm, and fixing the obtained filtrate with a washing reagent to obtain an extract; (3) centrifuging the extract at 400-600 rcf and 3-5° C. for 4-6 min, resuspending the precipitate obtained after centrifugation using a washing reagent or a resuspension reagent, and repeating the centrifugation and resuspension 1-3 times to obtain the precipitate that is the animal intestinal tissue cell nucleus; The resuspension reagent includes: 2% BSA, 1 mM DTT, 0.2 U / μL ribonuclease inhibitor and enzyme-free water.

10. An animal intestinal tissue cell nucleus suspension, characterized in that: The animal intestinal tissue cell nuclei in the animal intestinal tissue cell nucleus suspension are prepared by the extraction method according to any one of claims 1 to 9.